Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
!Book Name | !Book Name | ||
!Book Edition | !Book Edition | ||
!Book Acronym | |||
|- | |- | ||
|[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]] | |[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]] | ||
|5th | |5th | ||
|HAEM5 | |||
|- | |- | ||
| | | | ||
|5th | |5th | ||
| | |||
|- | |- | ||
|[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]] | |[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]] | ||
|5th | |5th | ||
|GTS5 | |||
|- | |- | ||
| | | | ||
|5th | |5th | ||
| | |||
|} | |} | ||
| Line 27: | Line 32: | ||
!Book Name | !Book Name | ||
!Book Edition | !Book Edition | ||
!Book Acronym | |||
|- | |- | ||
|[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]] | |[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]] | ||
|5th | |5th | ||
|EYE5 | |||
|- | |- | ||
|[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]] | |[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]] | ||
|5th | |5th | ||
|SKIN5 | |||
|- | |- | ||
|[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]] | |[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]] | ||
|5th | |5th | ||
|HAN5 | |||
|- | |- | ||
|[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]] | |[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]] | ||
|5th | |5th | ||
|ENDO5 | |||
|- | |- | ||
|[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]] | |[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]] | ||
|5th | |5th | ||
|MALE5 | |||
|- | |||
|[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]] | |||
|5th | |||
|PEDS5 | |||
|- | |- | ||
| | | | ||
|5th | |5th | ||
| | |||
|- | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | | | ||
| | | | ||
| | |||
|} | |} | ||